Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102


CD24 expression is important in male urothelial tumorigenesis and metastasis in mice and is androgen regulated.

Overdevest JB, Knubel KH, Duex JE, Thomas S, Nitz MD, Harding MA, Smith SC, Frierson HF, Conaway M, Theodorescu D.

Proc Natl Acad Sci U S A. 2012 Dec 18;109(51):E3588-96. doi: 10.1073/pnas.1113960109. Epub 2012 Sep 25.


CD24 offers a therapeutic target for control of bladder cancer metastasis based on a requirement for lung colonization.

Overdevest JB, Thomas S, Kristiansen G, Hansel DE, Smith SC, Theodorescu D.

Cancer Res. 2011 Jun 1;71(11):3802-11. doi: 10.1158/0008-5472.CAN-11-0519. Epub 2011 Apr 11.


Expression and prognostic significance of cancer stem cell markers CD24 and CD44 in urothelial bladder cancer xenografts and patients undergoing radical cystectomy.

Hofner T, Macher-Goeppinger S, Klein C, Schillert A, Eisen C, Wagner S, Rigo-Watermeier T, Baccelli I, Vogel V, Trumpp A, Sprick MR.

Urol Oncol. 2014 Jul;32(5):678-86. doi: 10.1016/j.urolonc.2014.01.001. Epub 2014 Mar 12.


Conditional Expression of the Androgen Receptor Increases Susceptibility of Bladder Cancer in Mice.

Johnson DT, Hooker E, Luong R, Yu EJ, He Y, Gonzalgo ML, Sun Z.

PLoS One. 2016 Feb 10;11(2):e0148851. doi: 10.1371/journal.pone.0148851. eCollection 2016.


Expression and significance of androgen receptor coactivators in urothelial carcinoma of the bladder.

Boorjian SA, Heemers HV, Frank I, Farmer SA, Schmidt LJ, Sebo TJ, Tindall DJ.

Endocr Relat Cancer. 2009 Mar;16(1):123-37. doi: 10.1677/ERC-08-0124. Epub 2008 Oct 9.


Decreased tumorigenesis and mortality from bladder cancer in mice lacking urothelial androgen receptor.

Hsu JW, Hsu I, Xu D, Miyamoto H, Liang L, Wu XR, Shyr CR, Chang C.

Am J Pathol. 2013 May;182(5):1811-20. doi: 10.1016/j.ajpath.2013.01.018. Epub 2013 Mar 13.


ELK1 is up-regulated by androgen in bladder cancer cells and promotes tumor progression.

Kawahara T, Shareef HK, Aljarah AK, Ide H, Li Y, Kashiwagi E, Netto GJ, Zheng Y, Miyamoto H.

Oncotarget. 2015 Oct 6;6(30):29860-76. doi: 10.18632/oncotarget.5007.


GON4L Drives Cancer Growth through a YY1-Androgen Receptor-CD24 Axis.

Agarwal N, Dancik GM, Goodspeed A, Costello JC, Owens C, Duex JE, Theodorescu D.

Cancer Res. 2016 Sep 1;76(17):5175-85. doi: 10.1158/0008-5472.CAN-16-1099. Epub 2016 Jun 16.


Constitutive β-catenin activation induces male-specific tumorigenesis in the bladder urothelium.

Lin C, Yin Y, Stemler K, Humphrey P, Kibel AS, Mysorekar IU, Ma L.

Cancer Res. 2013 Oct 1;73(19):5914-25. doi: 10.1158/0008-5472.CAN-12-4198. Epub 2013 Aug 8.


Loss of the urothelial differentiation marker FOXA1 is associated with high grade, late stage bladder cancer and increased tumor proliferation.

DeGraff DJ, Clark PE, Cates JM, Yamashita H, Robinson VL, Yu X, Smolkin ME, Chang SS, Cookson MS, Herrick MK, Shariat SF, Steinberg GD, Frierson HF, Wu XR, Theodorescu D, Matusik RJ.

PLoS One. 2012;7(5):e36669. doi: 10.1371/journal.pone.0036669. Epub 2012 May 10.


The metastasis-associated gene CD24 is regulated by Ral GTPase and is a mediator of cell proliferation and survival in human cancer.

Smith SC, Oxford G, Wu Z, Nitz MD, Conaway M, Frierson HF, Hampton G, Theodorescu D.

Cancer Res. 2006 Feb 15;66(4):1917-22.


Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder.

Miyamoto H, Yao JL, Chaux A, Zheng Y, Hsu I, Izumi K, Chang C, Messing EM, Netto GJ, Yeh S.

BJU Int. 2012 Jun;109(11):1716-26. doi: 10.1111/j.1464-410X.2011.10706.x. Epub 2012 Jan 5.


α4 contributes to bladder urothelial carcinoma cell invasion and/or metastasis via regulation of E-cadherin and is a predictor of outcome in bladder urothelial carcinoma patients.

Liu J, Cai M, Chen J, Liao Y, Mai S, Li Y, Huang X, Liu Y, Zhang J, Kung H, Zeng Y, Zhou F, Xie D.

Eur J Cancer. 2014 Mar;50(4):840-51. doi: 10.1016/j.ejca.2013.11.038. Epub 2014 Jan 2.


Androgen receptor signals regulate UDP-glucuronosyltransferases in the urinary bladder: a potential mechanism of androgen-induced bladder carcinogenesis.

Izumi K, Zheng Y, Hsu JW, Chang C, Miyamoto H.

Mol Carcinog. 2013 Feb;52(2):94-102. doi: 10.1002/mc.21833. Epub 2011 Nov 15.


N-cadherin increases after androgen deprivation and is associated with metastasis in prostate cancer.

Jennbacken K, Tesan T, Wang W, Gustavsson H, Damber JE, Welén K.

Endocr Relat Cancer. 2010 May 18;17(2):469-79. doi: 10.1677/ERC-10-0015. Print 2010 Jun.


Hyperplasia and carcinomas in Pten-deficient mice and reduced PTEN protein in human bladder cancer patients.

Tsuruta H, Kishimoto H, Sasaki T, Horie Y, Natsui M, Shibata Y, Hamada K, Yajima N, Kawahara K, Sasaki M, Tsuchiya N, Enomoto K, Mak TW, Nakano T, Habuchi T, Suzuki A.

Cancer Res. 2006 Sep 1;66(17):8389-96.


Role of androgen receptor and associated lysine-demethylase coregulators, LSD1 and JMJD2A, in localized and advanced human bladder cancer.

Kauffman EC, Robinson BD, Downes MJ, Powell LG, Lee MM, Scherr DS, Gudas LJ, Mongan NP.

Mol Carcinog. 2011 Dec;50(12):931-44. doi: 10.1002/mc.20758. Epub 2011 Mar 11.


Her-2/neu overexpression in muscle-invasive urothelial carcinoma of the bladder: prognostic significance and comparative analysis in primary and metastatic tumors.

Jimenez RE, Hussain M, Bianco FJ Jr, Vaishampayan U, Tabazcka P, Sakr WA, Pontes JE, Wood DP Jr, Grignon DJ.

Clin Cancer Res. 2001 Aug;7(8):2440-7.


Overexpression of CD24: association with invasiveness in urothelial carcinoma of the bladder.

Choi YL, Lee SH, Kwon GY, Park CK, Han JJ, Choi JS, Choi HY, Kim SH, Shin YK.

Arch Pathol Lab Med. 2007 Feb;131(2):275-81.


Overexpression of epidermal growth factor receptor in urothelium elicits urothelial hyperplasia and promotes bladder tumor growth.

Cheng J, Huang H, Zhang ZT, Shapiro E, Pellicer A, Sun TT, Wu XR.

Cancer Res. 2002 Jul 15;62(14):4157-63.

Supplemental Content

Support Center